Extra-genital Neisseria gonorrhoeae infections with genetic mutations conferring ciprofloxacin resistance among men who have sex with men and transgender women in Lima, Peru

Background The increasing prevalence of drug-resistant Neisseria gonorrhoeae (NG) infections has caused great concern. Ciprofloxacin remains the empiric antimicrobial recommended to treat NG infections in Peru disregarding the susceptibility profile of circulating NG strains. We report the prevalence of individuals infected with NG strains presenting mutations in the gyrA gene that confers ciprofloxacin resistance. Methods We conducted a descriptive study assessing extragenital swab samples collected from a cohort of men who have sex with men and transgender women in Lima, Peru. Anal and pharyngeal NG positive swabs for Aptima Combo 2 assay (Hologic Inc., USA) were used for DNA extraction. We performed TaqMan real time PCR assays to detect a point mutation at codon Ser91 of the gyrase A (gyrA) gene. Results From 156 individuals who had at least one positive sample for NG reported by the Aptima assay, 80 individuals had at least one amplified DNA for the gyrA gene. We found that 67 of them (84.0%) were infected with a gyrA-mutated NG strain at the Ser91 codon. Conclusions We report a high prevalence of gyrA mutation conferring ciprofloxacin resistance among individuals with extragenital NG infection. Empirical treatment of NG needs to be urgently updated in Peru in concordance with international guidelines.

[1]  M. Yagui,et al.  Antimicrobial Susceptibility of Neisseria gonorrhoeae Isolates From Peru, 2018 and 2019 , 2022, Sexually transmitted diseases.

[2]  Michael R. Wierzbicki,et al.  Resistance-Guided Treatment of Gonorrhea: A Prospective Clinical Study. , 2020, Clinical infectious diseases : an official publication of the Infectious Diseases Society of America.

[3]  S. Bruisten,et al.  Simultaneous Detection of Neisseria gonorrhoeae and Fluoroquinolone Resistance Mutations to Enable Rapid Prescription of Oral Antibiotics , 2020, Sexually transmitted diseases.

[4]  J. Klausner,et al.  Improved determination of Neisseria gonorrhoeae gyrase A genotype results in clinical specimens. , 2019, The Journal of antimicrobial chemotherapy.

[5]  I. Martin,et al.  World Health Organization Global Gonococcal Antimicrobial Surveillance Program (WHO GASP): review of new data and evidence to inform international collaborative actions and research efforts. , 2019, Sexual health.

[6]  P. Mayta-Tristán,et al.  Prevalencia y factores asociados a la compra de antimicrobianos sin receta médica, Perú 2016 , 2018, Revista Peruana de Medicina Experimental y Salud Pública.

[7]  Eddy R. Segura,et al.  High incidence of extra-genital gonorrheal and chlamydial infections among high-risk men who have sex with men and transgender women in Peru , 2018, International journal of STD & AIDS.

[8]  N. Low,et al.  Epidemiological, behavioural, and clinical factors associated with antimicrobial-resistant gonorrhoea: a review , 2018, F1000Research.

[9]  Maritza Mayta-Barrios,et al.  [Antimicrobial resistance of Neisseria gonorrhoeae in Peru]. , 2018, Revista peruana de medicina experimental y salud publica.

[10]  Liz Sánchez Palencia,et al.  Mutaciones en la región determinante de resistencia a quinolonas (QRDR) del gen gyrA de Neisseria gonorrhoeae presente en muestras clínicas de hombres que tienen sexo con hombres , 2017 .

[11]  M. Unemo,et al.  Antimicrobial resistance in Neisseria gonorrhoeae: Global surveillance and a call for international collaborative action , 2017, PLoS medicine.

[12]  J. Klausner,et al.  Wild-Type Gyrase A Genotype of Neisseria gonorrhoeae Predicts In Vitro Susceptibility to Ciprofloxacin: A Systematic Review of the Literature and Meta-Analysis , 2017, Sexually transmitted diseases.

[13]  Kelika A. Konda,et al.  The PICASSO Cohort: baseline characteristics of a cohort of men who have sex with men and male-to-female transgender women at high risk for syphilis infection in Lima, Peru , 2017, BMC Infectious Diseases.

[14]  J. Wallinga,et al.  Cost-Effectiveness of Dual Antimicrobial Therapy for Gonococcal Infections Among Men Who Have Sex With Men in the Netherlands , 2016, Sexually transmitted diseases.

[15]  Sebastian Bonhoeffer,et al.  Antibiotic-Resistant Neisseria gonorrhoeae Spread Faster with More Treatment, Not More Sexual Partners , 2016, PLoS pathogens.

[16]  J. Hinds,et al.  Accurate detection of Neisseria gonorrhoeae ciprofloxacin susceptibility directly from genital and extragenital clinical samples: towards genotype-guided antimicrobial therapy , 2016, The Journal of antimicrobial chemotherapy.

[17]  Eddy R. Segura,et al.  High prevalence of Chlamydia trachomatis and Neisseria gonorrhoeae infections in anal and pharyngeal sites among a community-based sample of men who have sex with men and transgender women in Lima, Peru , 2016, BMJ Open.

[18]  Eddy R. Segura,et al.  Characterizing the syphilis epidemic among men who have sex with men in Lima, Peru to identify new treatment and control strategies , 2013, BMC Infectious Diseases.

[19]  K. Holmes,et al.  Neisseria gonorrhoeae Antimicrobial Resistance Among Men Who Have Sex With Men and Men Who Have Sex Exclusively With Women: The Gonococcal Isolate Surveillance Project, 2005–2010 , 2013, Annals of Internal Medicine.

[20]  J. Dillon,et al.  Retrospective Analysis of Antimicrobial Susceptibility Trends (2000–2009) in Neisseria gonorrhoeae Isolates from Countries in Latin America and the Caribbean Shows Evolving Resistance to Ciprofloxacin, Azithromycin and Decreased Susceptibility to Ceftriaxone , 2012, Sexually transmitted diseases.

[21]  K. Holmes,et al.  Prevalences of sexually transmitted infections in young adults and female sex workers in Peru: a national population-based survey , 2012, The Lancet. Infectious diseases.

[22]  W. Shafer,et al.  Impact of fluoroquinolone resistance mutations on gonococcal fitness and in vivo selection for compensatory mutations. , 2012, Journal of Infectious Diseases.

[23]  M. Siedner,et al.  Detection of quinolone-resistant Neisseria gonorrhoeae in urogenital specimens with the use of real-time polymerase chain reaction , 2008, International journal of STD & AIDS.

[24]  P. Bloomfield.  Update on emerging infections: news from the Centers for Disease Control and Prevention. Update to CDC's Sexually Transmitted Diseases Treatment Guidelines, 2006: fluoroquinolones no longer recommended for treatment of gonococcal infections. , 2007, Annals of emergency medicine.

[25]  K. Holmes,et al.  Update to CDC's sexually transmitted diseases treatment guidelines, 2006: fluoroquinolones no longer recommended for treatment of gonococcal infections. , 2007, MMWR. Morbidity and mortality weekly report.

[26]  J. Klausner,et al.  Prevalence of and associated risk factors for fluoroquinolone-resistant Neisseria gonorrhoeae in California, 2000-2003. , 2005, Clinical infectious diseases : an official publication of the Infectious Diseases Society of America.

[27]  K. Holmes,et al.  Correlates of gonococcal infection and of antimicrobial-resistant Neisseria gonorrhoeae among female sex workers, Republic of the Philippines, 1996-1997. , 1999, The Journal of infectious diseases.